Landing
Macula Society 2026
OCT-F: AI-Enabled Retinal Function from Structural OCT – Results from OAKS and DERBY
Real-World Pegcetacoplan and Anti-VEGF Treatment Patterns Among Patients With Geographic Atrophy
Retrospective Comparative Analysis of Demographic and Clinical Profiles in Pegcetacoplan-Treated and Untreated Patients With Geographic Atrophy
Factors Affecting Disease Progression and Vision Loss in Geographic Atrophy: Findings from OAKS and DERBY
Earlier Treatment Yields Better Outcomes: 5 Years of Pegcetacoplan Treatment for Geographic Atrophy Secondary to AMD
Fellow Eye Analysis in Bilateral GA due to AMD: Long-term Data from the OAKS, DERBY, and GALE Studies
Can Visual Acuity be Estimated from Multimodal Imaging of Geographic Atrophy in Age-related Macular Degeneration?
AI in GA: Learnings From the Pegcetacoplan Clinical Program
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.